Avista files four-year rate plan in Washington to support reliable service and maintain critical infrastructure Proposal aims to deliver predictable costs while addressing grid upgrades, wildfire resiliency, and higher power supply expenses. GlobeNewswire January 16, 2026 SPOKANE, Wash., Jan. 16, 2026 (GLOBE NEWSWIRE) — Today Avista (NYSE: AVA) filed a four-year general rate case with […]

Oklahoma City, Ok, Jan. 16, 2026 (GLOBE NEWSWIRE) — Greta & Co Travel Design announces its next-generation luxury safari offerings for 2026, curated by acclaimed Virtuoso advisor Greta Meschke after an expansive journey through eight African countries. Drawing on deep local connections, industry recognition, and firsthand discovery, these new itineraries reflect a bold shift in

Award-Winning Virtuoso Advisor Unveils New Era of Luxury African Safaris for 2026 Insider Access, Transformative Experiences and Free Packing Guide for African Safari Travelers GlobeNewswire January 16, 2026 Oklahoma City, Ok, Jan. 16, 2026 (GLOBE NEWSWIRE) — Greta & Co Travel Design announces its next-generation luxury safari offerings for 2026, curated by acclaimed Virtuoso advisor

Sanmina Corporation (NASDAQ: SANM) announced today that it will host its first quarter fiscal 2026 earnings conference call on Monday, January 26, 2026 at 5:00 PM ET. The live webcast presentation and supporting materials will be available on the Sanmina website at www.sanmina.com in the Investor Relations section. A webcast replay will be available at

MetaVia Inc. (Nasdaq: MTVA) (MetaVia or the Company), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the closing of its previously announced underwritten public offering of Class A Units and Class B Units for gross proceeds of approximately $9.3 million, prior to deducting underwriting discounts and commissions and offering expenses and excluding

(NasdaqGM:CRVS), SOUTH SAN FRANCISCO, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, announced that it will host a conference call and webcast on Tuesday, January 20, 2026 at 8:00 am ET (5:00 am PT) to report the results from cohort 4 of the randomized, blinded, placebo-controlled Phase

(NasdaqGM:HIFS), HINGHAM, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) — HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), Hingham, Massachusetts announced earnings for the fourth quarter and the year ended December 31, 2025. Earnings Net income for the year ended December 31, 2025 was $54,551,000 or $25.01 per share basic and $24.76 per share diluted, as compared to

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis Company to host conference call and webcast on Tuesday, January 20, 2026 at 8:00 am ET / 5:00 am PT GlobeNewswire January 16, 2026 SOUTH SAN FRANCISCO, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals,

Hingham Savings Reports 2025 Results GlobeNewswire January 16, 2026 HINGHAM, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) — HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), Hingham, Massachusetts announced earnings for the fourth quarter and the year ended December 31, 2025. Earnings Net income for the year ended December 31, 2025 was $54,551,000 or $25.01 per share basic

International Paper (NYSE: IP; LSE: IPC) today declared a quarterly dividend of $0.4625 per share for the period from January 1, 2026 to March 31, 2026, inclusive, on the common stock, par value $1.00, of the Company, payable on March 17, 2026, to holders of record at the close of business on February 23, 2026.